This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It plays a critical role in the development of drugs targeting neurological and cardiovascular disorders, particularly those involving adrenergic receptors. Its structure, featuring a chiral center and functional groups, makes it valuable for creating enantiomerically pure compounds, which are essential for achieving specific therapeutic effects with reduced side effects. Additionally, it is employed in research settings for studying receptor binding mechanisms and for designing novel compounds with potential therapeutic applications.